What happened
ClinicalTrials.gov registry update for Department of Defense PTSD Adaptive Platform Trial - Intervention C - Daridorexant
SourceClinicalTrials.govclinical updateBiotech
Department of Defense PTSD Adaptive Platform Trial - Intervention C - Daridorexant
Clinical/translation signal: Department of Defense PTSD Adaptive Platform Trial - Intervention C - Daridorexant
Factual summary
Why it matters
Clinical trial registry updates are translation signals, not commercialization claims by themselves.
SourceClinicalTrials.govLimitations
ClinicalTrials.gov status does not prove product approval, licensing, revenue, or market adoption.
SourceClinicalTrials.govLinked output
Department of Defense PTSD Adaptive Platform Trial - Intervention C - Daridorexantclinical trialPeople
No reviewed person relationship is attached to this event.
Organizations
Topics
No reviewed topic relationship is attached to this event.
Problems
No reviewed problem relationship is attached to this event.
Relationship evidence
Department of Defense PTSD Adaptive Platform Trial - Intervention C - Daridorexant
Department of Defense PTSD Adaptive Platform Trial - Intervention C - Daridorexant (NCT05948540)
Timeline
- clinical updateDepartment of Defense PTSD Adaptive Platform Trial - Intervention C - Daridorexant